Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer

Study Overview

This randomized phase III trial studies whether weight loss in overweight and obese women may prevent breast cancer from coming back (recurrence).

Study Description

This randomized controlled trial of weight loss interventions in overweight and obese women with early stage breast cancer consists of two arms. The purpose of this study is to compare the effect of the telephone-based intervention versus a health educational control on invasive disease-free survival (IDFS).

Additional Information

Participants will not be paid for their participation.


  • IRB Number: 1610745694 (A011401)
  • Research Study Identifier: TX7114
  • Principal Investigator: Kathy Miller, MD

Recruitment Status

Open

Contact the research team to learn more about this study.

Fields marked with asterisk (*) are required

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Volunteer Sign up

Volunteer Registry

Create your profile and be matched to research opportunities

Register Now!

If you need assistance finding a study or if you have any questions, please email: ctsirro@iu.edu or call us at (317) 278-2176